The constitutional protection of trade secrets and patents under the Biologics Price Competition and Innovation Act of 2009.

نویسنده

  • Richard A Epstein
چکیده

The Biologics Price Competition and Innovation Act of 2009 ("Biosimilars Act") is for the field of pharmaceutical products the single most important legislative development since passage of the Drug Price Competition and Patent Term Restoration Act of 1984 ("Hatch-Waxman Act"), on which portions of the Biosimilars Act are clearly patterned. Congress revised section 351 of the Public Health Service Act (PHSA) to create a pathway for FDA approval of "biosimilar" biological products. Each biosimilar applicant is required to cite in its application a "reference product" that was approved on the basis of a full application containing testing data and manufacturing information, which is owned and was submitted by another company and much of which constitutes trade secret information subject to constitutional protection. Because the Biosimilars Act authorizes biosimilar applicants to cite these previously approved applications, the implementation of the new legislative scheme raises critical issues under the Fifth Amendment of the Constitution, pursuant to which private property--trade secrets included--may not be taken for public use, without "just compensation." FDA must confront those issues as it implements the scheme set out in the Biosimilars Act. This article will discuss these issues, after providing a brief overview of the Biosimilars Act and a more detailed examination of the law of trade secrets.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

نقش حقوق رقابت در بهبود سلامت عمومی

Competition as an important incentive for innovation leads to freedom of choice and price reduction and contributes to more rapid provision of new and effective therapeutic technologies. On the other hand, anti-competitive practices adopted by economic undertakings in the health sector may disrupt competition including limited access to medicines and medical services or increase in their price....

متن کامل

Trade Liberalization, Exchange Rate Changes, And the Competitiveness of Carbohydrate Staple Markets in Nigeria

This study examined the effects of trade liberalization and exchange rate changes on carbohydrate staples in Nigeria. Secondary data published from 1974 to 2006 on cassava exports and rice imports as well as non-tradable carbohydrate staples were used. It was hypothesized that exchange rate changes and trade liberalization via price relatives, trade intensity and nominal protection coefficient ...

متن کامل

Dynamic protection of innovations through patents and trade secrets

This paper analyzes the optimal protection strategy for an innovator of a complex innovation who faces the risk of imitation by a competitor. We suppose that the innovation can be continuously fragmented into sub-innovations. We characterize the optimal mix of patent and trade secrets when the innovator faces a strict novelty requirement and can only patent a fraction of the innovation once. We...

متن کامل

Law and Innovation: Evidence from the Uniform Trade Secrets Act

Most research and policy on protecting innovation focus on patents. Yet, almost all technology managers report secrecy to be more important than patents. Here, I show theoretically that stronger secrecy laws could increase or reduce R&D. By reducing spillovers, secrecy laws might reduce or raise the return to R&D, depending on whether spillover and own R&D are complements or substitutes. By str...

متن کامل

Protecting Trade Secrets in Canada.

Patents in the life sciences industries are a key form of intellectual property (IP), particularly for products such as brand-name drugs and medical devices. However, trade secrets can also be a useful tool for many types of innovations. In appropriate cases, trade secrets can offer long-term protection of IP for a lower financial cost than patenting. This type of protection must be approached ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Food and drug law journal

دوره 66 3  شماره 

صفحات  -

تاریخ انتشار 2011